Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients
The prophylactic use of defibrotide in pediatric HSCT recipients significantly reduces the incidence and severity of acute GVHD, with a modification of cytokine pattern, both strongly coherent with the protective drug’s action. Despite advances in acute graft-versus-host disease (aGVHD) prophylaxis,...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
Life Science Alliance LLC
2023-05-01
|
| Цуврал: | Life Science Alliance |
| Онлайн хандалт: | https://www.life-science-alliance.org/lookup/doi/10.26508/lsa.202201786 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|